Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Actuate Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 0 | 10 | +10 |
| Shares | 0 | 382.2K | +382.2K |
| Value | $0 | $2.85M | +$2.85M |
New holders (10)
Institutions that held Actuate Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AWM Investment Company, Inc. | 139,511 | $1.04M | 0.13% |
| Long Corridor Asset Management Ltd | 125,000 | $931.3K | 0.82% |
| Royal Bank of Canada | 35,300 | $263.0K | 0.00% |
| Geode Capital Management, LLC | 27,893 | $207.8K | 0.00% |
| Northwestern University | 27,778 | $206.9K | 0.24% |
| KG&L Capital Management,LLC | 12,000 | $89.4K | 0.03% |
| Citigroup Inc | 10,973 | $81.7K | 0.00% |
| Wells Fargo & Company | 3,392 | $25.3K | 0.00% |
| Tower Research Capital LLC (TRC) | 297 | $2.21K | 0.00% |
| Bank of America Corp | 23 | $171 | 0.00% |
Sold out (0)
Institutions that held Actuate Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
None.